• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白作为衰老与帕金森病相互作用的介质

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.

作者信息

Bobela Wojciech, Aebischer Patrick, Schneider Bernard Laurent

机构信息

Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.

出版信息

Biomolecules. 2015 Oct 16;5(4):2675-700. doi: 10.3390/biom5042675.

DOI:10.3390/biom5042675
PMID:26501339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4693253/
Abstract

Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson's disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, which include mitochondrial activity, as well as proteasome and autophagic degradation of proteins. Remarkably, these functions are also affected when the renewal of macromolecules and organelles becomes impaired during the normal aging process. As aging is considered a major risk factor for Parkinson's disease, it is critical to explore its molecular and cellular implications in the context of the alpha-synuclein pathology. Here, we discuss similarities and differences between normal brain aging and Parkinson's disease, with a particular emphasis on the nigral dopaminergic neurons, which appear to be selectively vulnerable to the combined effects of alpha-synuclein and aging.

摘要

α-突触核蛋白的积累和错误折叠是帕金森病发病机制的核心机制。虽然α-突触核蛋白的正常功能主要与囊泡神经传递的控制有关,但其致病作用与多种细胞功能相关,包括线粒体活性以及蛋白质的蛋白酶体和自噬降解。值得注意的是,当大分子和细胞器的更新在正常衰老过程中受损时,这些功能也会受到影响。由于衰老被认为是帕金森病的主要危险因素,在α-突触核蛋白病理学背景下探索其分子和细胞影响至关重要。在这里,我们讨论正常脑衰老和帕金森病之间的异同,特别强调黑质多巴胺能神经元,它们似乎对α-突触核蛋白和衰老的联合作用具有选择性易损性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b982/4693253/a7b1c5de9699/biomolecules-05-02675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b982/4693253/1ce12491f254/biomolecules-05-02675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b982/4693253/a7b1c5de9699/biomolecules-05-02675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b982/4693253/1ce12491f254/biomolecules-05-02675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b982/4693253/a7b1c5de9699/biomolecules-05-02675-g002.jpg

相似文献

1
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.α-突触核蛋白作为衰老与帕金森病相互作用的介质
Biomolecules. 2015 Oct 16;5(4):2675-700. doi: 10.3390/biom5042675.
2
Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.Rab1A 过表达可防止高尔基器碎裂,并在基于α-突触核蛋白的帕金森病大鼠模型中部分纠正运动缺陷。
J Parkinsons Dis. 2011;1(4):373-87. doi: 10.3233/JPD-2011-11058.
3
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.《拥挤的十字路口:帕金森病中线粒体、α-突触核蛋白与内溶酶体系统的相互作用》
Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312.
4
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?猴子和人类中与年龄相关的α-突触核蛋白增加与黑质纹状体多巴胺耗竭有关:这是帕金森病的靶点吗?
Neurobiol Dis. 2007 Jan;25(1):134-49. doi: 10.1016/j.nbd.2006.08.021. Epub 2006 Oct 18.
5
A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.帕金森病多巴胺能神经元细胞核和线粒体中 alpha-突触核蛋白的多方面遗传毒性网络:新兴概念和挑战。
Prog Neurobiol. 2020 Feb;185:101729. doi: 10.1016/j.pneurobio.2019.101729. Epub 2019 Dec 18.
6
Determinants of dopaminergic neuron loss in Parkinson's disease.帕金森病中多巴胺能神经元丧失的决定因素。
FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14.
7
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.α-突触核蛋白诱导帕金森病大鼠模型早期突触功能障碍。
Sci Rep. 2017 Jul 25;7(1):6363. doi: 10.1038/s41598-017-06724-9.
8
α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca homeostasis and mitochondrial ATP production.α-突触核蛋白与内质网-线粒体连接蛋白VAPB结合,破坏钙稳态和线粒体ATP生成。
Acta Neuropathol. 2017 Jul;134(1):129-149. doi: 10.1007/s00401-017-1704-z. Epub 2017 Mar 23.
9
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?帕金森病中的线粒体动态:α-突触核蛋白的作用?
Dis Model Mech. 2017 Sep 1;10(9):1075-1087. doi: 10.1242/dmm.026294.
10
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.

引用本文的文献

1
The association of glymphatic system function with cognitive decline in PD-FOG: multimodal MRI evidence from cross-sectional and longitudinal studies.帕金森病步态冻结中脑淋巴系统功能与认知衰退的关联:横断面和纵向研究的多模态磁共振成像证据
Brain Imaging Behav. 2025 Aug 11. doi: 10.1007/s11682-025-01044-3.
2
Identification of markers for neurescence through transcriptomic profiling of postmortem human brains.通过对人类死后大脑进行转录组分析来鉴定神经发生的标志物。
NPJ Aging. 2025 Jul 1;11(1):57. doi: 10.1038/s41514-025-00235-y.
3
Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with α-Synucleinopathy.

本文引用的文献

1
Network structure of brain atrophy in de novo Parkinson's disease.新发帕金森病脑萎缩的网络结构
Elife. 2015 Sep 7;4:e08440. doi: 10.7554/eLife.08440.
2
Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.格列酮类药物治疗与糖尿病患者帕金森病发病率:一项回顾性队列研究。
PLoS Med. 2015 Jul 21;12(7):e1001854. doi: 10.1371/journal.pmed.1001854. eCollection 2015 Jul.
3
Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.锰诱导的帕金森综合征与帕金森病:共同特征与可区分特征
视黄酸X受体作为治疗与α-突触核蛋白病相关神经疾病的治疗靶点。
Cells. 2025 May 9;14(10):685. doi: 10.3390/cells14100685.
4
Cerebral small vessel disease: The impact of glymphopathy and sleep disorders.脑小血管病:类淋巴系统功能障碍和睡眠障碍的影响
J Cereb Blood Flow Metab. 2025 May 5:271678X251333933. doi: 10.1177/0271678X251333933.
5
Identification of markers for neurescence through transcriptomic profiling of postmortem human brains.通过对死后人类大脑进行转录组分析来鉴定神经发生的标志物。
Res Sq. 2025 Apr 9:rs.3.rs-5903682. doi: 10.21203/rs.3.rs-5903682/v1.
6
Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson's disease.α-突触核蛋白果蝇模型中的纵向多组学研究区分帕金森病中与疾病相关和与年龄相关的病理变化。
NPJ Parkinsons Dis. 2025 Mar 11;11(1):46. doi: 10.1038/s41531-025-00899-z.
7
Establishing a robust triangulation framework to explore the relationship between hearing loss and Parkinson's disease.建立一个强大的三角测量框架,以探索听力损失与帕金森病之间的关系。
NPJ Parkinsons Dis. 2025 Jan 3;11(1):5. doi: 10.1038/s41531-024-00861-5.
8
Cognitive function in Parkinson's disease: associations with perivascular space in basal ganglia.帕金森病的认知功能:与基底节血管周围间隙的关系。
Neurol Sci. 2024 Dec;45(12):5973-5981. doi: 10.1007/s10072-024-07729-9. Epub 2024 Aug 30.
9
The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.脂多糖(LPS)与 A53T-α-突触核蛋白的协同作用研究:鼻腔内 LPS 暴露对帕金森病 A53T-α-突触核蛋白转基因小鼠模型的影响。
Mol Neurobiol. 2024 Sep;61(9):7046-7065. doi: 10.1007/s12035-024-04020-y. Epub 2024 Feb 17.
10
Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls.Sortilin 表达水平与外周免疫:帕金森病患者与健康对照人群分类的潜在生物标志物。
Int J Mol Sci. 2024 Feb 1;25(3):1791. doi: 10.3390/ijms25031791.
Int J Environ Res Public Health. 2015 Jul 6;12(7):7519-40. doi: 10.3390/ijerph120707519.
4
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation.导致帕金森病的α-突触核蛋白错义突变将天然四聚体转变为单体,作为疾病起始的一种机制。
Nat Commun. 2015 Jun 16;6:7314. doi: 10.1038/ncomms8314.
5
A cellular perspective on brain energy metabolism and functional imaging.从细胞角度看大脑能量代谢和功能成像。
Neuron. 2015 May 20;86(4):883-901. doi: 10.1016/j.neuron.2015.03.035.
6
PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.黑质多巴胺神经元中 PGC-1α 的活性决定了对 α-突触核蛋白的易感性。
Acta Neuropathol Commun. 2015 Apr 1;3:16. doi: 10.1186/s40478-015-0200-8.
7
Alpha-synuclein levels in blood plasma decline with healthy aging.随着健康衰老,血浆中的α-突触核蛋白水平会下降。
PLoS One. 2015 Apr 6;10(4):e0123444. doi: 10.1371/journal.pone.0123444. eCollection 2015.
8
Definition of a molecular pathway mediating α-synuclein neurotoxicity.介导α-突触核蛋白神经毒性的分子途径的定义。
J Neurosci. 2015 Apr 1;35(13):5221-32. doi: 10.1523/JNEUROSCI.4650-14.2015.
9
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.线粒体功能障碍和帕金森病中的自噬:从家族性到散发性疾病。
Trends Biochem Sci. 2015 Apr;40(4):200-10. doi: 10.1016/j.tibs.2015.02.003. Epub 2015 Mar 8.
10
Novel subcellular localization for α-synuclein: possible functional consequences.α-突触核蛋白的新型亚细胞定位:可能的功能后果。
Front Neuroanat. 2015 Feb 23;9:17. doi: 10.3389/fnana.2015.00017. eCollection 2015.